Tirzepatide at therapeutic doses (10-15 mg) produces enough appetite suppression and weight loss that adding a stimulant provides minimal additional benefit while introducing unnecessary risks
Under Section 503A, compounders could legally recreate the drug without FDA approval
If doctors could make millions and millions of dollars easily from offering quality menopause care at a reasonable price or from insurance, there would be a lot of doctors doing menopause care
Although the absolute risk of clinically recorded alopecia associated with GLP-1 receptor agonist use is low, the observed association may still influence patients satisfaction, adherence, and decisions to start or continue therapy, authors wrote
is currently investigating lawsuits on behalf of Ozempic and Wegovy users experiencing the following: If you are experiencing problems or have concerns about your medication, consult your doctor before starting or discontinuing any treatment
However, be honest with yourself here